The companies aim to reduce diabetic foot ulcers by combining wound care knowledge with technology systems

GOTHENBURG, Sweden—Mölnlycke Health Care, a medical technology company specializing in wound care solutions, announced an $8 million (USD) investment in Siren, a health care technology company. Siren aims to help reduce the risk of diabetic foot ulcers (DFU) by early detection of potential injuries through temperature-sensing textile technology.

Guillaume Joucla has been named chief financial officer of the Swedish medical device company

GOTHENBURG, Sweden—Mölnlycke Health Care, a Swedish medical technology company, announced Guillaume Joucla has been appointed as the company’s new chief financial officer (CFO). Joucla will take office as CFO and member of the company’s executive leadership team in January.